Butorphanol Tartrate (Mylan Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Butorphanol Tartrate drug offered from Mylan Pharmaceuticals Inc.. This Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Pharmaceuticals Inc.
NON-PROPRIETARY NAME: butorphanol tartrate
SUBSTANCE NAME: BUTORPHANOL TARTRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA]
ROUTE: NASAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2011-01-21
END MARKETING DATE: 0000-00-00


Butorphanol Tartrate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionButorphanol Tartrate from Mylan Pharmaceuticals Inc.
LABELER NAME: Mylan Pharmaceuticals Inc.
DEA SCHEDULE: CIV
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2011-01-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0378-9639_3d68b3d8-82c8-417f-9453-2ec617db936a
PRODUCT NDC: 0378-9639
APPLICATION NUMBER: ANDA075759

Other BUTORPHANOL TARTRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.Butorphanol Tartrate
Cardinal HealthButorphanol Tartrate
General Injectables & Vaccines, IncBUTORPHANOL TARTRATE
Hospira, Inc.Butorphanol Tartrate
Mylan Pharmaceuticals Inc.Butorphanol Tartrate
West-Ward Pharmaceuticals CorpButorphanol Tartrate
West-Ward Pharmaceuticals Corp.Butorphanol Tartrate